Gubra A/S (CPSE: GUBRA)
Health Care · Life Sciences Tools & Services · DK
Dkr290.60
+2.69% today · -32.2% 1Y
Gubra A/S (CPSE: GUBRA) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $696.24M and employs 330 people.
Over the last twelve months the share price has lost 32.2%, trading between 272.00 and 557.50.
Tweenvest scores Gubra A/S across four factors: quality 67/100, value 38/100, growth 100/100. Its strongest factor is growth.
GUBRA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $696.24M
- Revenue (TTM)
- $41.42M
- P/E
- —
- EPS
- -11.16
- Dividend yield
- —
- Beta (5Y)
- 0.45
- 52-week high
- Dkr557.50
- 52-week low
- Dkr272.00
- Avg volume (3M)
- —
- Shares outstanding
- 16.42M
- Employees
- 330
- Next earnings
- —
About Gubra A/S
Gubra A/S is a biotechnology firm engaged in two core activities: offering contract research organization (CRO) services for pre-clinical development, and advancing its own internal early-stage drug and target discovery initiatives. Its CRO division provides specialized pre-clinical research and development support to companies in the pharmaceutical and biotechnology sectors. These services encompass a wide range of capabilities, including in vivo pharmacology, tissue analysis, various assay development, molecular pharmacology, bioanalytical testing, next-generation sequencing (NGS), and both two-dimensional and three-dimensional imaging techniques. Established in 2008, the company has its headquarters in Horsholm, Denmark.
- ISIN
- DK0062266474
- Founded
- 2008
- Listed since
- Apr 4, 2023
- Exchange
- OMX Nordic Exchange Copenhagen
- Currency
- DKK
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Mesa Laboratories, Inc.NasdaqGS: MLAB | $713.53M | $127.24 | -0.21% |
| Cytek Biosciences, Inc.NasdaqGS: CTKB | $705.81M | $5.24 | -3.59% |
| Shanghai Model Organisms Center, Inc.SHSE: 688265 | $702.87M | CN¥60.93 | -6.23% |
| OmniAb, Inc.NasdaqGM: OABI | $696.42M | $4.80 | +0.21% |
| Curiox Biosystems Co., LtdKOSDAQ: A445680 | $684.61M | ₩53,500.00 | -8.08% |
| Innova Captab LimitedNSEI: INNOVACAP | $656.33M | Rs1,110.00 | -4.97% |
| Evotec SEXTRA: EVT | $550.90M | €2.46 | -11.13% |
| Jiangsu Hanbon Science and Technology Co., Ltd.SHSE: 688755 | $493.26M | CN¥28.88 | -4.50% |
Figures last refreshed Oct 11, 2026.